Medis Pharma Lithuania UAB Finance - revenue, profit
Financial ratios
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 970,032 |
| 129,857 |
| 28,206 |
| 18,673 |
| 2,500 |
| 55.98 |
| 1.92 |
| 46,743 |
| 81,589 |
| 8,499 |
| 124,279 |
| 2024 |
|---|
| 920,820 |
| 117,452 |
| 26,774 |
| 20,121 |
| 2,566 |
| 56.55 |
| 2.19 |
| 66,864 |
| 66,384 |
| 11,149 |
| 133,009 |
| 2025 |
|---|
| 1,309,030 |
| 148,923 |
| 50,119 |
| 38,651 |
| 4,397 |
| 61.25 |
| 2.95 |
| 105,516 |
| 57,102 |
| 9,992 |
| 169,264 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 1,309,030 |
| 148,923 |
| 50,119 |
| 38,651 |
| 4,397 |
| 61.25 |
| 2.95 |
| 105,516 |
| 57,102 |
| 9,992 |
| 169,264 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
1,309,030 €42 % *
Sales per employee (€)
148,923 €27 % *
Profit before tax (€)
50,119 €87 % *
Net Profit (€)
38,651 €92 % *
Profit per employee (€)
4,397 €71 % *
Total profitability (%)
61.25 %8.31 % *
Net profitability (%)
2.95 %34.70 % *
Equity (€)
105,516 €58 % *
Amounts Payable And Liabilities (€)
57,102 €-14 % *
Non-current Assets (€)
9,992 €-10 % *
CurrentAssets (€)
169,264 €27 % *
